Thanks to your support, we’re advancing diabetes research that’s changing lives. Right now, we’re funding 112 remarkable diabetes research projects, including 21 new ones in 2025.
"Since Jack has started insulin, his family, friends and school staff have mentioned how much more energy he has. He is our little super star and has been so brave and resilient." Save for later Page ...
The Driving and Vehicle Licensing Agency (DVLA) will now allow people with diabetes who hold Group 2 licences to use continuous glucose monitoring to monitor their blood glucose levels when driving.
We take a look at some of the exciting diabetes research developments announced in August, and what the findings could mean for people living with or affected by diabetes.
The first ever immunotherapy for type 1 diabetes has been licensed for use in the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) has decided teplizumab, also known as Tzield, is ...
Our new stigma research looks at diabetes stigma at scale across the UK. With blame, shame and stigma staggeringly high across type 1 diabetes and type 2 diabetes – what can be done to tackle it?
We explain what causes gestational diabetes, what the most common risk factors are and how you can take steps to reduce your risk.
In partnership with Tesco, we surveyed 2,000 people to get an insight into people’s understanding and awareness of diabetes.
Our research has provided the most detailed picture yet of how weight loss improves health. The findings offer important clues about how losing weight can help people with type 2 diabetes improve ...
On Thursday 3 July the government published its 10 Year Health Plan, setting out its ambition to rebuild the NHS and bring care closer to home.
Find out more about the remission weight loss programme which offers most people living with type 2 diabetes the best chance of going into remission.
Lucy, our Head of Research Impact and Communications, shares the moment she was diagnosed with type 1 diabetes. And how research has revealed that her journey with type 1 began long before any ...